You Are On:
EQUITY
Equity Analysis
  Price
    Gainers & Losers
    Out & Under Performers
    Only Buyers & Sellers
     Advances & Declines
     New Highs & Lows
     Weightage
     5 Day's Up & Down
  Volume
  Analysis
News Analysis
Corporate Info
Corporate Action
Other Market
Cash Flow    
Medicamen Biotech Ltd.
 
BSE Code 531146
ISIN Demat INE646B01010
Book Value 158.50
NSE Code MEDICAMEQ
Dividend Yield(%) 0.19
Market Cap(Million) 6827.10
P/E(X) 47.94
EPS(Rs.) 11.20
Face Value(Rs.) 10  
Type
(Rs. in Million)
ParticularsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Profit Before Tax170.45180.94163.94179.80173.53
Adjustment85.6270.3534.2828.0922.39
Changes In working Capital-287.77-178.21-25.90-36.37-112.91
Cash Flow after changes in Working Capital-31.7073.09172.32171.5283.01
Cash Flow from Operating Activities-62.9341.09127.72128.0243.01
Cash Flow from Investing Activities-58.80-84.73-178.13-372.91-147.57
Cash Flow from Financing Activities291.2742.9858.39190.63-36.90
Net Cash Inflow / Outflow169.54-0.667.98-54.27-141.46
Opening Cash & Cash Equivalents38.2538.9130.9385.19226.65
Cash & Cash Equivalent on Amalgamation / Take over / Merger00000
Cash & Cash Equivalent of Subsidiaries under liquidations00000
Translation adjustment on reserves / op cash balalces frgn subsidiaries00000
Effect of Foreign Exchange Fluctuations00000
Closing Cash & Cash Equivalent207.7938.2538.9130.9385.19